Org 25935 is a new putative antipsychotic agent developed by N.V. Organon.The primary
objective of this study is to investigate the effect of Org 25935 on ketamine-induced
impairments in immediate recall.
- Male, 18 - 55 years
- History of sensitivity/idiosyncrasy to the drugs used in the study or chemically
related compounds or excipients which may be employed in the study or to any other
unknown drug used in the past.
Deepak C D'Souza, M.D.
Yale University, School of Medicine, Department of Psychiatry